SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001553350-17-000825
Filing Date
2017-07-11
Accepted
2017-07-10 17:47:27
Documents
7
Period of Report
2017-05-03
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT - AMENDMENT NO. 1 htbx_8k.htm 8-K/A 17535
2 AUDITOR'S CONSENT htbx_ex23z1.htm EX-23.1 1887
3 AUDITED FINANCIAL STATEMENTS htbx_ex99z1.htm EX-99.1 300703
4 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION htbx_ex99z2.htm EX-99.2 185607
5 GRAPHIC htbx_ex99z1001.jpg GRAPHIC 239245
6 GRAPHIC htbx_ex99z1002.jpg GRAPHIC 239245
7 GRAPHIC htbx_ex99z1003.jpg GRAPHIC 2963
  Complete submission text file 0001553350-17-000825.txt   1170311
Mailing Address 801 CAPITOLA DRIVE DURHAM NC 27713
Business Address 801 CAPITOLA DRIVE DURHAM NC 27713 919-240-7133
HEAT BIOLOGICS, INC. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-35994 | Film No.: 17958660
SIC: 2834 Pharmaceutical Preparations